DDrare: Database of Drug Development for Rare Diseases

Epaxal berna (virosomal hepatitis a vaccine) (DrugBank: Hepatitis A Vaccine)

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	0
96	クローン病	1
97	潰瘍性大腸炎	1

46. 悪性関節リウマチ　［臨床試験数：4,183，薬物数：2,538（DrugBank：401），標的遺伝子数：183，標的パスウェイ数：219］

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 4,183 trial found

96. クローン病　［臨床試験数：2,209，薬物数：1,276（DrugBank：240），標的遺伝子数：166，標的パスウェイ数：210］

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,209 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01341808 (ClinicalTrials.gov)	April 2011	25/4/2011	Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients	Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis A	Biological: Epaxal Berna (virosomal hepatitis A vaccine)	Asan Medical Center	NULL	Completed	18 Years	40 Years	Both	493	Phase 4	Korea, Republic of

97. 潰瘍性大腸炎　［臨床試験数：2,269，薬物数：1,331（DrugBank：241），標的遺伝子数：114，標的パスウェイ数：181］

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,269 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01341808 (ClinicalTrials.gov)	April 2011	25/4/2011	Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients	Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis A	Biological: Epaxal Berna (virosomal hepatitis A vaccine)	Asan Medical Center	NULL	Completed	18 Years	40 Years	Both	493	Phase 4	Korea, Republic of